116 related articles for article (PubMed ID: 7251726)
21. High-performance liquid chromatographic determination of vinca-alkaloids in plasma and urine.
De Smet M; Van Belle SJ; Storme GA; Massart DL
J Chromatogr; 1985 Dec; 345(2):309-21. PubMed ID: 4086600
[TBL] [Abstract][Full Text] [Related]
22. [Simultaneous determination of vinburnine and 6-hydroxyvinburnine in human plasma by high-performance liquid chromatography].
Sado PA; Gibassier D; Leverge R
J Chromatogr; 1988 Dec; 434(1):157-67. PubMed ID: 3243809
[TBL] [Abstract][Full Text] [Related]
23. Effect of Vincamine on CBF under pharmacokinetic aspects.
Witzmann HK; Siegers CP; Heiss WD; Kohlmeyer K
Acta Neurol Scand Suppl; 1977; 64():410-1. PubMed ID: 268853
[No Abstract] [Full Text] [Related]
24. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography.
Kraus G; Schulz HU; Lohmann A
J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968
[TBL] [Abstract][Full Text] [Related]
25. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
[TBL] [Abstract][Full Text] [Related]
26. [Vincamine concentrations in plasma and cerebrospinal fluid in patients following intravenous infusion (author's transl)].
Siegers CP; Heiss WD; Kohlmeyer K
Arzneimittelforschung; 1977; 27(6a):1274-7. PubMed ID: 578452
[TBL] [Abstract][Full Text] [Related]
27. Chromatographic analysis of Vinca alkaloids in human neoplastic tissues and host (mouse) tissues after injection in vivo or after incubation in vitro.
Houghton JA; Torrance PM; Houghton PJ
Anal Biochem; 1983 Oct; 134(2):450-4. PubMed ID: 6650830
[TBL] [Abstract][Full Text] [Related]
28. Phytochemical Investigation of Vinca minor Cultivated in Iran.
Farahanikia B; Akbarzadeh T; Jahangirzadeh A; Yassa N; Shams Ardekani MR; Mirnezami T; Hadjiakhoondi A; Khanavi M
Iran J Pharm Res; 2011; 10(4):777-85. PubMed ID: 24250413
[TBL] [Abstract][Full Text] [Related]
29. Determination of apovincaminic acid in biological samples by high-performance liquid chromatography.
Kozma M; Pudleiner P; Vereczkey L
J Chromatogr; 1982 May; 241(1):177-82. PubMed ID: 7107794
[TBL] [Abstract][Full Text] [Related]
30. Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
Ramírez J; Ogan K; Ratain MJ
Cancer Chemother Pharmacol; 1997; 39(4):286-90. PubMed ID: 9025768
[TBL] [Abstract][Full Text] [Related]
31. [Vincamine N4-mononitrate (author's transl)].
Voigtländer HW; Pohl L
Arch Pharm (Weinheim); 1978 Sep; 311(9):804-6. PubMed ID: 708214
[No Abstract] [Full Text] [Related]
32. Pharmacokinetics and metabolism of vincamine and related compounds.
Vereczkey L
Eur J Drug Metab Pharmacokinet; 1985; 10(2):89-103. PubMed ID: 3899662
[TBL] [Abstract][Full Text] [Related]
33. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
[No Abstract] [Full Text] [Related]
34. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
Petruzzi E; Bucalossi A
Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
[No Abstract] [Full Text] [Related]
35. [Effects of vincamine on the mesenteric circulation in the rat. Microcirculatory evaluation of the vasodilator activity of vincamine].
Piacenza G; Pesce E
Farmaco Prat; 1978 Jul; 33(7):326-32. PubMed ID: 744233
[No Abstract] [Full Text] [Related]
36. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
[TBL] [Abstract][Full Text] [Related]
37. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
Ritschel WA; Mandybur TI; Grummich KW; Means ED
Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
[TBL] [Abstract][Full Text] [Related]
38. [Assay and bioavailability of vincamine (author's transl)].
Jaminet F; Schneck G; Polastro E; Lejeune A
J Pharm Belg; 1981; 36(6):421-5. PubMed ID: 7328483
[No Abstract] [Full Text] [Related]
39. [Kinetic behavior of 3H-vincamine in man. Compartmental analysis].
Camón L; Rodríguez Farré E; Valdecasas FG
Arch Farmacol Toxicol; 1978 Apr; 4(1):39-40. PubMed ID: 697401
[No Abstract] [Full Text] [Related]
40. [Synthesis of 1-ethyl-1,2,3,4,6,7-hexahydroindolo-[2,3a]-quinolizinium perchlorate, a key intermediate of vincamine].
Chen GX; Guo RK
Yao Xue Xue Bao; 1983 Jul; 18(7):507-13. PubMed ID: 6659953
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
